Literature DB >> 33589048

The recommended lifetime immunization schedule from the board of vaccination calendar for life in Italy: A continuing example of impact on public health policies.

P Bonanni1, A Villani2, S Scotti3, P Biasci4, R Russo2, T Maio3, G Vitali Rosati4, A Moscadelli5, G Conforti4, C Azzari2, A Ferro5, F Francia5, G Chiamenti4, M Barretta4, P Castiglia5, P Macrì6, M Conversano5, E Bozzola2, I F Angelillo5.   

Abstract

The Vaccination Calendar for Life is an alliance of scientific and professional societies of public health physicians, paediatricians and general practitioners in Italy which provides a periodical update on the ideal, scientifically driven vaccination calendar throughout lifetime. Since 2012, the Lifetime Immunization Schedule has represented a benchmark for Regional and National Authorities to set up the updated list of vaccines provided actively and free of charge to infants, children, adolescents, adults and the elderly by inclusion in the Triennial National Vaccination Plan (TNVP), and in the Essential Levels of Care (LEA). The impact of the different editions of the Lifetime Immunization Schedule on the TNVP was deep, representing the inspiring source for the present vaccination policy. The 2019 edition called for more attention to pregnant women immunization; risk groups vaccination; uniform high coverage with the MMRV vaccine; extension of Meningococcal B vaccination also at adolescent age; use of quadrivalent conjugate meningococcal vaccine also at 1 year of life; progressive decrease of the age of free-of-charge offer of influenza to ≥ 60 and then to ≥ 50 year-old population; implementation of flu immunization ages 6 months-6 years; HPV vaccination also offered to 25-year old women at the time of the first screening (gender neutral immunization already offered); sequential PCV13-PPV23 pneumococcal vaccination in 65 year-old subjects; increased coverage with rotavirus vaccine in infants and zoster vaccine in the elderly.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Lifetime immunization schedule; Public health; Vaccination strategies

Year:  2021        PMID: 33589048     DOI: 10.1016/j.vaccine.2021.01.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  The public health and the question of the "best vaccine".

Authors:  Silvio Tafuri; Francesco Paolo Bianchi; Pasquale Stefanizzi
Journal:  Vaccine       Date:  2022-05-26       Impact factor: 4.169

Review 2.  Improving vaccination rates in older adults and at-risk groups: focus on pertussis.

Authors:  Jung-Hyun Choi; Jaime Correia de Sousa; Monica Fletcher; Giovanni Gabutti; Lauriane Harrington; Michael Holden; Hyungwoo Kim; Jean-Pierre Michel; Piyali Mukherjee; Terry Nolan; Tobias Welte; Stefania Maggi
Journal:  Aging Clin Exp Res       Date:  2022-01-10       Impact factor: 3.636

3.  Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018-2020.

Authors:  Pasquale Stefanizzi; Francesco Paolo Bianchi; Andrea Martinelli; Antonio Di Lorenzo; Paola De Petro; Giusi Graziano; Sabrina Lattanzio; Giusy Diella; Paolo Stella; Domenica Ancona; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2022-02-24       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.